Webinar on ThruPLEX DNA-seq
Hear Dr. Liang Wang from the Medical College of Wisconsin discuss how ThruPLEX technology was used to study the potential clinical research use of cell-free DNA from urine in predicting treatment response and monitoring disease progression in prostate cancer patients.
ThruPLEX 12S (12 Rxn) Kit to be Discontinued on June 15, 2016More
Rubicon Genomics expands Asia distribution; 2016 AACR data presentation shows utility of ThruPLEX® Plasma-seq Cell-free NGS libraries from Liquid BiopsiesMore
Rubicon Genomics Announces Distribution Agreement with Beckman Coulter Life Sciences for its ThruPLEX® Plasma-Seq KitsMore
Rubicon Genomics Adds New Distributors as Product Sales Continued to Accelerate in 2015More
What Our Customers Say
"Your ThruPLEX Plasma-seq Kit is the easiest to follow and has the most streamlined protocol (importantly with the fewest clean-up steps). We successfully made libraries from 1ng input in this trial."
"Our experience with the ThruPLEX library prep has been extremely positive. Both at Rubicon and in our hands it has proven able to generate high quality, diverse libraries from 10x less input than other kits we have used. For us this technology truly enables the study of samples that simply weren’t possible before adopting it.”
“Using PicoPLEX we can combine highly accurate chromosome screening, using array-CGH or SNP microarrays, with diagnosis of single gene disorders via PCR amplification plus mutation detection or again using SNP array.”